Skip to Content
Merck
  • Association study in a South Indian population supports rs1015213 as a risk factor for primary angle closure.

Association study in a South Indian population supports rs1015213 as a risk factor for primary angle closure.

Investigative ophthalmology & visual science (2013-07-13)
Roopam Duvesh, Anshuman Verma, Rengaraj Venkatesh, Srinivasan Kavitha, Pradeep Y Ramulu, Robert Wojciechowski, Periasamy Sundaresan
ABSTRACT

Three loci defined by single nucleotide polymorphisms (SNPs) rs11024102 in PLEKHA7, rs3753841 in COL11A1, and rs1015213 between the PCMTD1 and ST18 genes, recently have been associated with primary angle closure glaucoma (PACG). We explored the genetic association of these SNPs with subtypes of primary angle closure in a South Indian population. The study included three case definitions: primary angle closure/primary angle closure glaucoma (PAC/PACG, N = 180); primary angle closure suspect (PACS, N = 171), and a combined any-angle closure group. Controls consisted of 411 individuals from South India. Genotyping for all three SNPs was performed using the TaqMan allelic discrimination assay. Genetic association was estimated using a χ(2) test statistics and logistic regression. Among the three studied SNPs, significant genetic association was identified for rs1015213 in the PAC/PACG (P = 0.002) and any-angle closure (P = 0.003) analyses. However, no significant genetic association was seen when in PACS subjects (P = 0.052). SNPs rs3753841 and rs11024102 showed no evidence of genetic association with angle-closure phenotypes (P > 0.05) in South Indian participants. In our study, rs1015213 (located in the intergenic region between PCMTD1 and ST18) was associated significantly with PAC/PACG, confirming prior reports of an association between this region and angle closure glaucoma. Further work with a larger sample size is necessary to confirm the importance of COL11A1 and PLEKHA7 in the pathogenesis of glaucoma.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-PCMTD1 antibody produced in rabbit, IgG fraction of antiserum